Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Colon cancer--understanding how NSAIDs work.

× No keyword cloud information.

35 in total

1. Phospho-NSAIDs have enhanced efficacy in mice lacking plasma carboxylesterase: implications for their clinical pharmacology.

Authors: Chi C Wong; Ka-Wing Cheng; Ioannis Papayannis; George Mattheolabakis; Liqun Huang; Gang Xie; Nengtai Ouyang; Basil Rigas
Journal: Pharm Res Date: 2014-11-13 Impact factor: 4.200

Review 2. Part 2: pharmacogenetic variability in drug transport and phase I anticancer drug metabolism.

Authors: Maarten J Deenen; Annemieke Cats; Jos H Beijnen; Jan H M Schellens
Journal: Oncologist Date: 2011-05-31

3. Phospho-ibuprofen (MDC-917) incorporated in nanocarriers: anti-cancer activity in vitro and in vivo.

Authors: T Nie; C C Wong; N Alston; P Aro; P P Constantinides; B Rigas
Journal: Br J Pharmacol Date: 2012-06 Impact factor: 8.739

4. Heparanase powers a chronic inflammatory circuit that promotes colitis-associated tumorigenesis in mice.

Authors: Immanuel Lerner; Esther Hermano; Eyal Zcharia; Dina Rodkin; Raanan Bulvik; Victoria Doviner; Ariel M Rubinstein; Rivka Ishai-Michaeli; Ruth Atzmon; Yoav Sherman; Amichay Meirovitz; Tamar Peretz; Israel Vlodavsky; Michael Elkin
Journal: J Clin Invest Date: 2011-04-01 Impact factor: 14.808

5. Significance of heparanase in cancer and inflammation.

Authors: Israel Vlodavsky; Phillip Beckhove; Immanuel Lerner; Claudio Pisano; Amichai Meirovitz; Neta Ilan; Michael Elkin
Journal: Cancer Microenviron Date: 2011-08-03

6. Serum oxylipin profiles in IgA nephropathy patients reflect kidney functional alterations.

Authors: Angela M Zivkovic; Jun Yang; Katrin Georgi; Christine Hegedus; Malin L Nording; Aifric O'Sullivan; J Bruce German; Ronald J Hogg; Robert H Weiss; Curt Bay; Bruce D Hammock
Journal: Metabolomics Date: 2012-12 Impact factor: 4.290

7. Genetic polymorphisms in fatty acid metabolism genes and colorectal cancer.

Authors: M Crous-Bou; G Rennert; R Salazar; F Rodriguez-Moranta; H S Rennert; F Lejbkowicz; L Kopelovich; S M Lipkin; S B Gruber; V Moreno
Journal: Mutagenesis Date: 2012-03 Impact factor: 3.000

8. A simple algebraic cancer equation: calculating how cancers may arise with normal mutation rates.

Authors: Peter Calabrese; Darryl Shibata
Journal: BMC Cancer Date: 2010-01-05 Impact factor: 4.430

9. Sulindac suppresses beta-catenin expression in human cancer cells.

Authors: Anjia Han; Zibo Song; Chang Tong; Dong Hu; Xiuli Bi; Leonard H Augenlicht; Wancai Yang
Journal: Eur J Pharmacol Date: 2008-02-05 Impact factor: 4.432

10. Selective inhibition of prostaglandin E2 receptors EP2 and EP4 induces apoptosis of human endometriotic cells through suppression of ERK1/2, AKT, NFkappaB, and beta-catenin pathways and activation of intrinsic apoptotic mechanisms.

Authors: Sakhila K Banu; JeHoon Lee; V O Speights; Anna Starzinski-Powitz; Joe A Arosh
Journal: Mol Endocrinol Date: 2009-04-30